Pharmacodynamics of glucose regulation by methylprednisolone. II. Normal rats

Biopharmaceutics and Drug Disposition

Volumn 30, Issue 1, 2009, Pages 35-48

  Jin, Jin Y ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Corticosterone; Glucose; Insulin; Methylprednisolone; Pharmacodynamics; Pharmacokinetics

Indexed keywords

CORTICOSTERONE; GLUCOSE; INSULIN; METHYLPREDNISOLONE;

ADRENAL SUPPRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIABETES MELLITUS; DIABETOGENESIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; HORMONAL REGULATION; HORMONE ACTION; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; LOW DRUG DOSE; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE;

ADRENAL CORTEX HORMONES; ALGORITHMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; CORTICOSTERONE; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCONEOGENESIS; GLUCOSE; HOMEOSTASIS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; INSULIN; MALE; METHYLPREDNISOLONE; RATS; RATS, WISTAR;

EID: 59949094365     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.642     Document Type: Article

References (21)

1. Baxter JD. Glucocorticoid hormone action. Pharmacol Ther 1976; 2: 605-669.
2. Baxter JD, Forsham PH. Tissue effects of glucocorticoids. Am J Med 1972; 53: 573-589.
3. Wilcke JR, Davis LE. Review of glucocorticoid pharmacology. Vet Clin North Am Small Anim Pract 1982; 12: 3-17.
4. Pellacani A, Fornengo P, Bruno A et al. Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest 1999; 29: 861-867.
5. Jin JY, Jusko WJ. Pharmacodynamics of glucose regulation by methylprednisolone I. Adrenalectomized rats. In press (2008); [companion article].
6. Haughey DB, Jusko WJ. Analysis of methylprednisolone, methylprednisone and corticosterone for assessment of methylprednisolone disposition in the rat. J Chromatogr 1988; 430: 241-248.
7. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1993; 21: 457-478.
8. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. J Pharmacol Exp Ther 2002; 300: 245-256.
9. Krzyzanski W. FOURPHARM User's Guide: A Computer Program Applying Fourier Analysis to Biorhythmic Data. Buffalo, NY, 2000.
10. Krzyzanski W, Chakraborty A, Jusko WJ. Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models. Chronobiol Int 2000; 17: 77-93.
11. Chakraborty A, Krzyzanski W, Jusko WJ. Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. J Pharmacokinet Biopharm 1999; 27: 23-43.
12. D'Argenio DZ, Schumitzky A. ADAPT II User's Guide Pharmacokinetic/ Pharmacodynamic Systems Analysis Software. BioMedical Simulations Resource: Los Angeles, CA, 1997.
13. Flakoll PJ, Carlson MG, Cherrington AD. Chapter 14. Physiologic action of insulin. In: LeRoith D, Taylor SI, Olefsky JM. (Eds.), Diabetes Mellitus. A Fundamental and Clinical Text, 2nd edn. Lippincott Williams & Wilkins: Philadelphia, 2000; 148-161.
14. Milad MA, Ludwig EA, Anne S, Middleton Jr E, Jusko WJ. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J Pharmacokinet Biopharm 1994; 22: 469-480.
15. Chow FS, Sharma A, Jusko WJ. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone. J Pharmacokinet Biopharm 1999; 27: 559-575.
16. Meno-Tetang GM, Hon YY, Van Wart S, Jusko WJ. Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat. Drug Metabol Drug Interact 1999; 15: 51-70.
17. Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987; 65: 482-487.
18. Lefkowitz RJ, Hoffman BB, Taylor P. Chapter 6. Neurotransmission: the autonomic and somatic motor nervous systems. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill: New York, 1996.
19. Hoffman BB, Lefkowitz RJ. Chapter 10. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill: New York, 1996.
20. Freedman MR, Stern JS, Reaven GM, Mondon CE. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats. Horm Metab Res 1986; 18: 296-298.
21. Ahren B, Lundquist I. Adrenalectomy and chemical sympathectomy by 6-hydroxydopamine. Effects on basal and stimulated insulin secretion. Pflugers Arch 1981; 390: 17-21.